Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
PyBOP → 5-(3-Chloro-4-isopropoxyphenyl)-3-(1H-indol-5-yl)-1,2,4-oxadiazole
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | PyBOP | HCID 2724699 | — |
| 반응물 | 3-Chloro-4-(propan-2-yloxy)benzoic acid | HCID 22597728 | — |
| 반응물 | HCID 178513238 | HCID 178513238 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 5-(3-Chloro-4-isopropoxyphenyl)-3-(1H-indol-5-yl)-1,2,4-oxadiazole | HCID 59318353 | 11.9% |
반응 단계
D1 (500 mg), D4 (611 mg) and PyBOP (1.66 g) were dissolved in DMF and stirred overnight. The reaction mixture was then evaporated and partitioned between EtOAc and H2O. The organic layer was washed with H2O (×2) then brine, dried over MgSO4, filtered and evaporated to give the crude product. This was purified on a silica cartridge, eluting with a 0 to 50% mixture of Et2O in hexane to give the title compound (120 mg) as a white solid. δH (CDCl3, 400 MHz): 1.43 (6H, d), 4.69 (1H, septet), 6.92 (1H, s), 7.04 (1H, d), 7.25 (1H, s), 7.48 (1H, d), 8.00 (1H, d), 8.07 (1H, d), 8.25 (1H, s), 8.39 (1H, br. s), 8.50 (1H, s). MS (ES): C19H16ClN3O2 requires 353; found 354 (MH+).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08101775B2 |
| 출처 데이터셋 | uspto-grants-2012_01 |
| ORD ID | ord-4f7805d80bb0444b915b9cd35f8d77b5 |
| 출처 메모 | uspto-grants-2012_01 |